Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer

NCT00065533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pemetrexed

Sponsor

Eli Lilly and Company